Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal development
- 29 March 2006
- journal article
- case report
- Published by BMJ in Journal of Medical Genetics
- Vol. 43 (10) , 788-792
- https://doi.org/10.1136/jmg.2005.034140
Abstract
Myopathy, encephalopathy, lactic acidosis, and stroke-like (MELAS) syndrome, a maternally inherited disorder that is among the most common mitochondrial DNA (mtDNA) diseases, is usually associated with the m.3242A>G mutation of the mitochondrial tRNA(leu) gene. Very few data are available with respect to prenatal diagnosis of this serious disease. The rate of mutant versus wild-type mtDNA (heteroplasmy) in fetal DNA is indeed considered to be a poor indicator of postnatal outcome. Taking advantage of a novel semi-quantitative polymerase chain reaction test for m.3243A>G mutant load assessment, we carried out nine prenatal diagnoses in five unrelated women, using two different fetal tissues (chorionic villi v amniocytes) sampled at two or three different stages of pregnancy. Two of the five women, although not carrying m.3243A>G in blood or extra-blood tissues, were, however, considered at risk for transmission of the mutation, as they were closely related to MELAS-affected individuals. The absence of 3243A>G in the blood of first degree relatives was associated with no mutated mtDNA in the cardiovascular system (CVS) or amniocytes, and their three children are healthy, with a follow-up of 3 months-3 years. Among the six fetuses from the three carrier women, three were shown to be homoplasmic (0% mutant load), the remaining three being heteroplasmic, with a mutant load ranging from 23% to 63%. The fetal mutant load was fairly stable at two or three different stages of pregnancy in CVS and amniocytes. Although pregnancy was terminated in the case of the fetus with a 63% mutant load, all other children are healthy with a follow-up of 3 months-6 years. These data suggest that a prenatal diagnosis for MELAS syndrome might be helpful for at-risk families.Keywords
This publication has 12 references indexed in Scilit:
- Single cell quantification of the 8993T>G NARP mitochondrial DNA mutation by fluorescent PCRMolecular Genetics and Metabolism, 2005
- Prenatal diagnosis of a fetus harboring an intermediate load of the A3243G mtDNA mutation in a maternal carrier diagnosed with MELAS syndromePrenatal Diagnosis, 2004
- Heteroplasmy of the A3243G transition of mitochondrial tRNA Leu(UUR) in a MELAS case and in a 25-week-old miscarried fetusZeitschrift für Neurologie, 2000
- Genetic Counseling and Prenatal Diagnosis for the Mitochondrial DNA Mutations at Nucleotide 8993American Journal of Human Genetics, 1999
- MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspringBrain, 1998
- Coamplification of Nuclear Pseudogenes and Assessment of Heteroplasmy of Mitochondrial DNA MutationsBiochemical and Biophysical Research Communications, 1998
- Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness.Journal of Medical Genetics, 1995
- Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues.Journal of Medical Genetics, 1994
- MELAS: Clinical features, biochemistry, and molecular geneticsAnnals of Neurology, 1992
- A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathiesNature, 1990